Financialsexperimental

SCANSOURCE, INC. (SCSC). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.

Income Statement Balance Sheet Cash FlowQuarterly Annual

USD in thousands

Cash Flow	Q4 FY26 30 Jun 2026	Q3 FY26 31 Mar 2026	Q2 FY26 31 Dec 2025	Q1 FY26 30 Sept 2025	Q4 FY25 30 Jun 2025	Q3 FY25 31 Mar 2025	Q2 FY25 31 Dec 2024	Q1 FY25 30 Sept 2024	Q4 FY24 30 Jun 2024	Q3 FY24 31 Mar 2024	Q2 FY24 31 Dec 2023	Q1 FY24 30 Sept 2023	Q4 FY23 30 Jun 2023	Q3 FY23 31 Mar 2023	Q2 FY23 31 Dec 2022	Q1 FY23 30 Sept 2022	Q4 FY22 30 Jun 2022	Q3 FY22 31 Mar 2022	Q2 FY22 31 Dec 2021	Q1 FY22 30 Sept 2021
Net income	25,618*	16,883*	16,494*	19,878	20,090*	17,430*	17,054*	16,974	16,096*	12,806*	32,726*	15,432	18,812*	21,221*	25,734*	24,042	19,947*	23,526*	23,252*	22,073
Net income from continuing operations				19,878									17,095*	21,221*			19,947*	23,526*	23,152*	22,073
Net income from discontinued operations													1,717*	0*			0*	0*	100*	0
Gain on sale of business					0*	0*			-378*	0*
Depreciation and amortization	5,782*	5,713*	5,938*	6,200	7,100*	7,492*	8,132*	7,471	6,792*	6,742*	7,258*	7,217	7,255*	7,074*	7,057*	7,228	7,700*	7,305*	7,229*	7,650
Amortization of debt issue costs	90*	91*	338*	96	97*	96*	97*	96	97*	96*	97*	96	96*	96*	96*	289	104*	104*	105*	104
Provision for doubtful accounts	580*	-204*	3,652*	1,928	652*	1,774*	4,247*	1,678	2,454*	1,391*	315*	4,157	933*	1,819*	-92*	125	1,358*	-765*	1,948*	-1,027
Share-based compensation	3,572*	3,955*	3,660*	2,876	2,674*	2,896*	3,021*	2,471	1,808*	2,389*	2,571*	2,769	2,586*	2,954*	3,363*	2,316	2,871*	2,760*	3,462*	2,570
Deferred income taxes	6,174*	-1,641*	-2,047*	2,079	-810*	-368*	-127*	2,433	-907*	138*	-3,006*	1,303	-2,905*	477*	-1,342*	2,274	3,742*	2,104*	74*	-183
Change in fair value of contingent consideration	-890*	440*	1,209*	314	-147*	904*											0*	0*	0*	0
Finance lease interest	7*	14*	13*	15	17*	21*	23*	25	31*	24*	31*	15	13*	7*	22*	2	2*	6*	9*	17
Contingent consideration payments excess																	0*	0*
Accounts receivable	-140,560*	-16,743*	-54,933*	79,010	-68,452*	-7,669*	504*	20,606	-5,510*	68,195*	22,295*	53,284	-64,020*	96,193*	-30,742*	-18,799	-98,535*	-13,034*	-27,656*	-26,714
Inventories	-35,387*	5,346*	13,956*	-20,574	-5,702*	18,260*	6,792*	9,524	12,279*	44,710*	82,538*	99,630	-2,056*	10,569*	-84,634*	-62,192	-27,613*	-22,818*	-69,652*	-25,879
Prepaid expenses and other assets	9,094*	-11,923*	-4,317*	5,262	-710*	8,393*	1,572*	-1,952	10,359*	-16,587*	-3,833*	-7,743	-6,525*	8,691*	15,797*	14,690	-12,369*	-3,766*	-10,062*	-1,174
Other non-current assets	827*	5,898*	-4,413*	552	-370*	1,199*	-140*	3,285	-16,711*	2,814*	-8,019*	11,227	-5,810*	5,396*	2,301*	-9,469	3,914*	-1,230*	-2,252*	691
Accounts payable	105,953*	66,311*	48,914*	-70,297	54,032*	14,556*	-47,913*	-17,002	39,693*	17,278*	-64,846*	-70,292	30,061*	-94,537*	34,873*	-1,053	15,434*	42,091*	52,406*	-26,962
Accrued expenses and other liabilities	16,635*	-2,758*	5,630*	-3,758	8,478*	-3,798*	-2,578*	744	-15,210*	19,016*	14,086*	-21,764	2,585*	-3,512*	-100*	-13,168	7,876*	-7,615*	9,553*	-14,683
Income taxes payable	233*	-31*	-3,253*	-370	-9,304*	4,876*	1,985*	-1,523	3,090*	1,139*	-4,456*	-1,798	5,431*	-1,610*	780*	5,256	-3,114*	1,039*	-6,735*	6,558
Net cash provided by operating activities	-2,272*	71,351*	30,841*	23,211		66,062*	-6,188*	44,830		160,151*	63,224*	93,533		54,838*	-26,887*	-48,459
Net cash provided by (used in) operating activities of continuing operations																	-78,683*	29,707*	-18,419*	-56,959
Capital expenditures	-2,517*	-2,399*	-1,975*	-2,395	-2,517*	-1,421*	-1,973*	-2,375	-1,270*	-2,420*	-2,550*	-2,315	-3,430*	-2,287*	-2,504*	-1,758	-3,523*	-681*	-1,555*	-1,090
Proceeds from the sale of discontinued operations														0*				0*
Proceeds from sale of business, net of cash transferred		0*				0*				0*
Cash paid for business acquisitions, net of cash acquired	-0*	138*	-18,358*	-0	-0*	-0*	176*	-56,849
Net cash (used in) provided by investing activities	-2,517*	-2,261*	-20,333*	-2,395		-1,421*	772*	-59,224		-2,420*	15,428*	-2,315		-2,287*	-2,504*	-1,758
Net cash (used in) provided by investing activities of continuing operations																	-3,523*	-681*	1,570*	-1,090
Borrowings on revolving credit, net of expenses	103,879*	47,647*	92,528*	49,210	13,618*	11,749*	18,206*	8,381	16,813*	108,286*	546,059*	588,570	627,257*	639,851*	653,047*	579,011	569,139*	482,109*	588,524*	526,637
Repayments on long-term debt				-2,236	-1,875*	-1,875*	-3,750*	-357	-1,875*	-1,875*	-2,227*	-938	-937*	-938*	-937*	18,402	-1,875*	-1,875*	-1,875*	-2,218
Repayments on revolving credit, net of expenses	-103,881*	-47,647*	-92,528*	-49,210	-13,618*	-11,750*	-18,206*	-8,430	-16,763*	-129,166*	-623,305*	-669,424	-607,471*	-710,657*	-595,750*	-542,147	-477,593*	-495,600*	-587,139*	-470,237
Debt issuance costs	-0*	23*							-0*	-0*	-0*	-0	-0*	-0*	-0*	-1,407
Borrowings on long-term debt	0*	0*
Repayments on long-term debt	-625*	-625*
Repayments of finance lease obligations	-235*	-240*	-252*	-271	-272*	-271*	-272*	-275	-379*	-143*	-251*	-191	23*	-120*	-1,263*	771	-306*	-308*	-308*	-316
Contingent consideration payments	-0*	-0*	-0*	-1,375													-0*	-0*
Exercise of stock options	103*	2*	20*	4,834	7*	15*	2,518*	6,971	187*	317*	4,237*	72	57*	219*	624*	10	712*	478*	120*	994
Taxes paid on settlement of equity awards	-177*	-221*	-17*	-2,617	-76*	-14*	-11*	-4,794	-82*	-137*	-1,075*	-1,582	-30*	-101*	-1,736*	-596	-25*	-95*
Repurchase of common stock	-26,515*	-32,698*	-17,402*	-21,285	-25,265*	-28,917*	-24,216*	-28,126	-21,727*	-19,917*			-4,933*	-10,718*			-9,676*	-8,344*
Net cash (used in) provided by financing activities of continuing operations																	80,376*	-23,635*	-3,495*	54,860
Net cash (used in) financing activities	-27,451*	-33,759*	-50,318*	-22,950		-31,063*	-25,731*	-26,630		-42,635*	-77,813*	-83,493		-82,464*	53,985*	54,044
Net cash flows provided by operating activities of discontinued operations																	0*	0*	0*	0
Effect of exchange rate changes on cash and cash equivalents	319*	1,498*	-1,648*	901	2,223*	2,189*	-3,377*	608	-2,855*	-1,033*	1,501*	-1,256	1,812*	842*	1,379*	-1,342	-3,722*	4,025*	-1,024*	-4,038
(Decrease) increase in cash and cash equivalents	-31,921*	36,829*	-41,458*	-1,233	-20,130*	35,767*	-34,524*	-40,416	26,410*	114,063*	2,340*	6,469	-1,196*	-29,071*	25,973*	2,485	-5,552*	9,416*	-21,368*	-7,227
Net cash flows used in financing activities of discontinued operations																	0*	0*	0*	0
Cash and cash equivalents at beginning of period	120,295*	83,466*	124,924*	126,157	146,287*	110,520*	145,044*	185,460	159,050*	44,987*	42,647*	36,178	37,374*	66,445*	40,472*	37,987	43,539*	34,123*	55,491*	62,718
Net cash flows used in investing activities of discontinued operations																	0*	0*	0*	0
Cash and cash equivalents at end of period	88,374	120,295	83,466	124,924	126,157	146,287	110,520	145,044	185,460	159,050	44,987	42,647	36,178	37,374	66,445	40,472	37,987	43,539	34,123	55,491
Net cash flows used in by discontinued operations																	0*	0*	0*	0
Cash and cash equivalents of continuing operations					126,157				185,460				36,178				37,987	43,539	34,123	55,491
Cash and cash equivalents of discontinued operations																	0	0	0	0